Gary Patou - Net Worth and Insider Trading
Gary Patou Net Worth
The estimated net worth of Gary Patou is at least $219,380 dollars as of 2024-05-12. Gary Patou is the Director of Xenon Pharmaceuticals Inc and owns about 4,902 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $198,727. Gary Patou is also the Chief Medical Officer of Pacira BioSciences Inc and owns about 702 shares of Pacira BioSciences Inc (PCRX) stock worth over $20,653. Details can be seen in Gary Patou's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gary Patou has not made any transactions after 2023-12-14 and currently still holds the listed stock(s).
Transaction Summary of Gary Patou
Gary Patou Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gary Patou owns 2 companies in total, including Xenon Pharmaceuticals Inc (XENE) , and Pacira BioSciences Inc (PCRX) .
Click here to see the complete history of Gary Patou’s form 4 insider trades.
Insider Ownership Summary of Gary Patou
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2023-12-14 | director |
| PCRX | Pacira BioSciences Inc | 2014-08-07 | Chief Medical Officer |
Gary Patou Latest Holdings Summary
Gary Patou currently owns a total of 2 stocks. Among these stocks, Gary Patou owns 4,902 shares of Xenon Pharmaceuticals Inc (XENE) as of December 14, 2023, with a value of $198,727 and a weighting of 90.59%. Gary Patou also owns 702 shares of Pacira BioSciences Inc (PCRX) as of August 7, 2014, with a value of $20,653 and a weighting of 9.41%.
Latest Holdings of Gary Patou
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2023-12-14 | 4,902 | 40.54 | 198,727 |
| PCRX | Pacira BioSciences Inc | 2014-08-07 | 702 | 29.42 | 20,653 |
Holding Weightings of Gary Patou
Gary Patou Form 4 Trading Tracker
According to the SEC Form 4 filings, Gary Patou has made a total of 3 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 7,598 shares on December 14, 2023, which brought Gary Patou around $311,898.
According to the SEC Form 4 filings, Gary Patou has made a total of 0 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years. The most-recent trade in Pacira BioSciences Inc is the sale of 20,000 shares on August 7, 2014, which brought Gary Patou around $2 Million.
Insider Trading History of Gary Patou
- 1
Gary Patou Trading Performance
GuruFocus tracks the stock performance after each of Gary Patou's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gary Patou is -10.63%. GuruFocus also compares Gary Patou's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gary Patou within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gary Patou's insider trading performs compared to the benchmark.
Performance of Gary Patou
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.04 | | | | | |
| Relative Return to S&P 500(%) | 7.84 | | | | | |
Gary Patou Ownership Network
Gary Patou Owned Company Details
What does Xenon Pharmaceuticals Inc do?
Who are the key executives at Xenon Pharmaceuticals Inc?
Gary Patou is the director of Xenon Pharmaceuticals Inc. Other key executives at Xenon Pharmaceuticals Inc include SVP Bus. & Corp. Development Sherrington Robin , director & PRESIDENT & CEO Ian Mortimer , and Chief Medical Officer Christopher John Kenney .
Xenon Pharmaceuticals Inc (XENE) Insider Trades Summary
Over the past 18 months, Gary Patou made 3 insider transaction in Xenon Pharmaceuticals Inc (XENE) with a net sale of 30,570. Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 150,477 shares made by Simon N. Pimstone , a net sale of 31,655 shares made by Ian Mortimer , and a net sale of 25,000 shares made by Dawn Svoronos .
In summary, during the past 3 months, insiders sold 22,229 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 22,229 shares. During the past 18 months, 260,631 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 260,631 shares.
Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xenon Pharmaceuticals Inc Insider Transactions
Gary Patou Mailing Address
Above is the net worth, insider trading, and ownership report for Gary Patou. Currently GuruFocus does not have mailing address information for Gary Patou.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
